Article
MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.
Science translational medicine - 10 Jun 2015
Evans Brian C, Hocking Kyle M, Osgood Michael J, Voskresensky Igor, Dmowska Julia, Kilchrist Kameron V, Brophy Colleen M, Duvall Craig L
Abstract excerpt
Autologous vein grafts are commonly used for coronary and peripheral artery bypass but have a high incidence of intimal hyperplasia (IH) and failure. We present a nanopolyplex (NP) approach that efficiently delivers a mitogen-activated protein kinase (MAPK)-activated protein (MAPKAP) kinase 2 inh...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
